StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.48−0.12 (-7.50%)

Close on Nov 17, 2026Market cap $87.66MP/E –Yield –

Adagene total assets

Total assets on the balance sheet at the end of each period.

Adagene's total assets was $133.58M at Jun 30, 2026. For fiscal 2025 it was $78.26M, down 12.3% from the year before. The highest annual figure on record is $189.51M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.26M-12.3%
FY2024Dec 31, 2024$89.27M-22.9%
FY2023Dec 31, 2023$115.73M-24.1%
FY2022Dec 31, 2022$152.40M-19.6%
FY2021Dec 31, 2021$189.51M+124.9%
FY2020Dec 31, 2020$84.26M-20.4%
FY2019Dec 31, 2019$105.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$133.58M+32.5%
Q4 FY2025Dec 31, 2025$78.26M-32.4%
Q2 FY2025Jun 30, 2025$66.52M-56.4%
Q4 FY2024Dec 31, 2024$89.27M-52.9%
Q2 FY2024Jun 30, 2024$100.78M+19.6%
Q4 FY2023Dec 31, 2023$115.73M+9.3%
Q4 FY2022Dec 31, 2022$152.40M–
Q4 FY2021Dec 31, 2021$189.51M–
Q4 FY2020Dec 31, 2020$84.26M–
Q4 FY2019Dec 31, 2019$105.89M–

More Adagene figures

See a number that looks wrong?